Abiopharma

🔍 Sclar Jeremy M. (Executive)

Company: ProMIS Neurosciences Inc. (PMN)

Report Date: 2025-07-25

Detailed Transactions and Holdings:

• Acquired 697,674 shares of Common Shares, no par value (Direct)
  Date: 2025-07-25 | Code: X | equity_swap_involved: 0 | shares_owned_after: 2,315,111.00 | transaction_form_type: 4 | Footnotes: F1, F1, F2
• Acquired 697,674 shares of Common Shares, no par value (Direct)
  Date: 2025-07-25 | Code: X | equity_swap_involved: 0 | shares_owned_after: 3,012,785.00 | transaction_form_type: 4 | Footnotes: F3, F3, F2
• Acquired 697,674 shares of Common Shares, no par value (Direct)
  Date: 2025-07-25 | Code: X | equity_swap_involved: 0 | shares_owned_after: 3,710,459.00 | transaction_form_type: 4 | Footnotes: F4, F4, F2
• Holds 0 shares of Common Shares, no par value (Direct)
  Date: 2025-07-25 | Code: H | nature_of_ownership: By Crocker Mountain LLC | shares_owned_after: 1,155,726.00 | Footnotes: F5
• Holds 0 shares of Common Shares, no par value (Direct)
  Date: 2025-07-25 | Code: H | shares_owned_after: 65,000.00
• Sold 697,674 shares of Tranche A Common Share Purchase Warrants (Derivative)
  Date: 2025-07-25 | Code: X | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F1, F1, F2
• Sold 697,674 shares of Tranche B Common Share Purchase Warrants (Derivative)
  Date: 2025-07-25 | Code: X | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F3, F3, F3, F2
• Sold 697,674 shares of Tranche C Common Share Purchase Warrants (Derivative)
  Date: 2025-07-25 | Code: X | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F4, F4, F4, F2
• Acquired 3,139,533 shares of Warrant to Purchase Common Shares (Derivative)
  Date: 2025-07-29 | Code: P | equity_swap_involved: 0 | shares_owned_after: 3,139,533.00 | transaction_form_type: 4 | Footnotes: F6, F6, F6, F6, F2

Footnotes:

• F1: On July 25, 2025, the Jeremy M. Sclar 2012 Irrevocable Family Trust (the "JS Trust") exercised 697,674 Tranche A purchase warrants, each exercisable to purchase one Common Share. These warrants were exercisable at an exercise price of $2.02 per warrant share; however, following an offer by the JS Trust and an acceptance by the Issuer, were exercised in full at an exercise price of $0.83518 per share.
• F2: Held through the JS Trust, a trust formed under a trust instrument governed by the laws of the Commonwealth of Massachusetts. Mr Sclar's spouse is one of the trustees of the JS Trust.
• F3: On July 25, 2025, the JS Trust exercised 697,674 Tranche B purchase warrants, each exercisable to purchase one Common Share. These warrants were exercisable at an exercise price of $2.02 per warrant share; however, following an offer by the JS Trust and an acceptance by the Issuer, were exercised in full at an exercise price of $0.83518 per share.
• F4: On July 25, 2025, the JS Trust exercised 697,674 Tranche C purchase warrants, each exercisable to purchase one Common Share. These warrants were exercisable at an exercise price of $2.50 per warrant share; however, following an offer by the JS Trust and an acceptance by the Issuer, were exercised in full at an exercise price of $0.83518 per share.
• F5: Held through Crocker Mountain LLC, a Maine Limited liability company ("Crocker Mountain"). Mr Sclar is the sole manager of Crocker Mountain.
• F6: On July 29, 2025, the JS Trust acquired a warrant to purchase 3,139,533 Common Shares at an exercise price of $1.25 per share. The purchase price for the warrant was $0.1875 per Common Share underlying the warrant. The warrant is currently exercisable and expires five years after the date of issuance.